Skip to main content

Table 1 Baseline clinico-pathological characteristics (n = 102)

From: A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab

Parameter

N (%)

Age years (median, range)

69 (44–85)

Height

168 cm (152–186)

Weight

69.5 kg (45–175)

Gender

 Male

69 (68%)

 Female

33 (32%)

ECOG PS

 0

53 (52%)

 1

41 (40%)

 2

8 (8%)

Lung parenchyma metastasis

 Yes

68 (67%)

 No

34 (34%)

Lymph node metastasis

 Yes

72 (71%)

 No

30 (29%)

Loco-regional lymph node metastasis

 Yes

31 (30%)

 No

71 (70%)

Liver metastasis

 Yes

19 (19%)

 No

83 (81%)

Brain metastasis

 Yes

14 (14%)

 No

88 (86%)

Malignant pleural effusion

 Yes

9 (9%)

 No

93 (91%)

Bone metastasis

 Yes

27 (26%)

 No

75 (74%)

Adrenal gland metastasis

 Yes

11 (11%)

 No

91 (89%)

N. of metastatic sites

 1

21 (21%)

 2

34 (33%)

 3

47 (46%)